Product NDC: | 0703-4014 |
Proprietary Name: | Leuprolide Acetate |
Non Proprietary Name: | Leuprolide Acetate |
Active Ingredient(s): | 1 mg/.2mL & nbsp; Leuprolide Acetate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-4014 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075471 |
Marketing Category: | ANDA |
Start Marketing Date: | 20001106 |
Package NDC: | 0703-4014-18 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 KIT (0703-4014-18) > 2.8 mL in 1 VIAL, MULTI-DOSE (0703-4014-11) |
NDC Code | 0703-4014-18 |
Proprietary Name | Leuprolide Acetate |
Package Description | 1 VIAL, MULTI-DOSE in 1 KIT (0703-4014-18) > 2.8 mL in 1 VIAL, MULTI-DOSE (0703-4014-11) |
Product NDC | 0703-4014 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Leuprolide Acetate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20001106 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | LEUPROLIDE ACETATE |
Strength Number | 1 |
Strength Unit | mg/.2mL |
Pharmaceutical Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] |